health π¬ Algeria's lung cancer care gets a major glow-up
Precision oncology is fundamentally changing lung cancer treatment decisions across Algeria. The latest Algerian National Therapeutic Guidelines embrace molecular diagnostics and biomarker-guided therapy for advanced NSCLC. These 2026 recommendations shift focus to individual tumor biology over simple treatment choices. Curative management now heavily relies on multidisciplinary tumor boards for complex Stage III cases. This evolution shows Algeria aligning with global precision medicine standards. π¬